Interferon Alpha Treatment and Endocrine Disease
Year: 2003
Type: review
Abstract: The interferons are a group of proteins with antiviral activity, growth regulatory properties, and a wide variety of immunomodulatory activities. There is evidence that, when interferon a is used therapeutically in chronic hepatitis B and C and in certain malignancies,1–5 it can precipitate or exacerbate autoimmune endocrine diseases, especially of the thyroid gland.6 In this review we examine the published information on such unwanted effects. THYROID GLAND The thyroid gland is the most extensively studied in relation to the effect of interferon a: more than forty reports document changes in thyroid function and autoimmune markers during treatment of hepatitis C. In the largest series, 11 241 consecutive patients with hepatitis C were treated with interferon a, of whom 71 (0.6%) developed
Institutions: Chinese University of Hong Kong, Prince of Wales Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2147691396
